Literature DB >> 14991392

False-positive human immunodeficiency virus antibody test in a dialysis patient.

Douglas M Silverstein1, Diego H Aviles, V Matti Vehaskari.   

Abstract

A patient developed end-stage renal disease secondary to p-anti-neutrophil cytoplasmic antibody (p-ANCA) positive rapidly progressive glomerulonephritis. He subsequently had human immunodeficiency virus (HIV)-1 antibody screening performed as part of a pre-transplant evaluation. The HIV-1 enzyme immunoassay (EIA) antibody test was repeatedly reactive. The HIV-1 western blot was indeterminate. The western blot pattern revealed "non-specific staining obscuring bands in that region." Another sample of serum was sent and the results were identical to the first result. An HIV-1 proviral qualitative polymerase chain reaction test was then performed several months later and no HIV-1 DNA was detected. One year later, an HIV-1 RNA test was negative. Thus, the positive antibody EIA test and the indeterminate western blot represent a false-positive result, most likely due to cross-reacting antigens in the patient's serum with various HIV antibodies. Throughout this period and thereafter, the patient has exhibited no symptoms of HIV infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14991392     DOI: 10.1007/s00467-003-1405-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  15 in total

1.  Heterophile antibodies to bovine and caprine proteins causing false-positive human immunodeficiency virus type 1 and other enzyme-linked immunosorbent assay results.

Authors:  J H Willman; T B Martins; T D Jaskowski; H R Hill; C M Litwin
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

2.  False-positive HIV antibody test following alpha-interferon therapy in a chronic hemodialysis patient.

Authors:  C Sungur; T Akpolat; C Ozkuyumcu; U Yasavul; C Turgan; S Caglar
Journal:  Nephron       Date:  1994       Impact factor: 2.847

3.  Circulating immune complexes in regularly dialyzed patients with chronic renal failure.

Authors:  G O Perez; P Glasson; H Favre; J P Wauters; G Benzonana; M Jeannet; P H Lambert
Journal:  Am J Nephrol       Date:  1984       Impact factor: 3.754

4.  Anti-HIV indeterminate western blot in dialysis patients: a long-term follow-up.

Authors:  N Vardinon; I Yust; O Katz; A Iaina; Z Katzir; D Modai; M Burke
Journal:  Am J Kidney Dis       Date:  1999-07       Impact factor: 8.860

5.  Earlier detection of human immunodeficiency virus type 1 p24 antigen and immunoglobulin G and M antibodies to p17 antigen in seroconversion serum panels by immune complex transfer enzyme immunoassays.

Authors:  S Hashida; S Ishikawa; K Hashinaka; I Nishikata; S Oka; E Ishikawa
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

6.  Are antiphospholipid antibodies clinically relevant in dialysis patients?

Authors:  S L Chew; R L Lins; R Daelemans; P Zachee; L S De Clerck; J Vermylen
Journal:  Nephrol Dial Transplant       Date:  1992       Impact factor: 5.992

7.  Immune complex transfer enzyme immunoassay that is more sensitive and specific than western blotting for detection of antibody immunoglobulin G to human immunodeficiency virus type 1 in serum with recombinant pol and gag proteins as antigens.

Authors:  S Hashida; K Hashinaka; I Nishikata; S Oka; K Shimada; A Saito; A Takamizawa; H Shinagawa; S Yano; H Kojima
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

8.  Performance characteristics of serologic tests for human immunodeficiency virus type 1 (HIV-1) antibody among Minnesota blood donors. Public health and clinical implications.

Authors:  K L MacDonald; J B Jackson; R J Bowman; H F Polesky; F S Rhame; H H Balfour; M T Osterholm
Journal:  Ann Intern Med       Date:  1989-04-15       Impact factor: 25.391

9.  Anti-interleukin-1 alpha autoantibodies in hemodialysis patients.

Authors:  G Sunder-Plassmann; P L Sedlacek; R Sunder-Plassmann; K Derfler; K Swoboda; V Fabrizii; M M Hirschl; P Balcke
Journal:  Kidney Int       Date:  1991-10       Impact factor: 10.612

10.  Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States.

Authors:  E M Lackritz; G A Satten; J Aberle-Grasse; R Y Dodd; V P Raimondi; R S Janssen; W F Lewis; E P Notari; L R Petersen
Journal:  N Engl J Med       Date:  1995-12-28       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.